Company Encyclopedia
View More
name
SPDR S&P Health
XHS.US
News
View More

SCS Capital Management LLC Has $26.12 Million Holdings in HCA Healthcare, Inc. $HCA

SCS Capital Management LLC increased its holdings in HCA Healthcare by 137.9% in Q2, owning 68,180 shares worth $26.12 million. Analysts have varied ratings for HCA, with Barclays, TD Cowen, and others raising price targets. HCA reported Q3 earnings of $6.96 per share, surpassing estimates, with revenue up 9.6% year-over-year. The company announced a quarterly dividend of $0.72, payable on December 29th.

Market Beat·
US
HCA
-0.29%
Market Beat·
US
HCA
-0.29%

Norges Bank Purchases Shares of 460,024 Universal Health Services, Inc. $UHS

Norges Bank acquired 460,024 shares of Universal Health Services, valued at approximately $83.33 million, in the second quarter, as per its latest SEC filing. This purchase represents 0.71% ownership of UHS by Norges Bank. Several other institutional investors have also adjusted their positions in UHS. The stock has received mixed ratings from analysts, with a consensus target price of $234.14.

Market Beat·
US
UHS
-0.19%
Market Beat·
US
UHS
-0.19%

HCA Healthcare Announces $4.8 Million Gift to Help Launch Pepperdine University’s School of Nursing | HCA Stock News

HCA Healthcare announced a $4.8 million donation to Pepperdine University to support the launch of its School of Nursing. This initiative aims to address the national nursing shortage by investing in nursing education. The new facility includes advanced clinical simulation labs and offers undergraduate and graduate programs. HCA Healthcare has been actively supporting nursing education through various investments and expansions, including Galen College of Nursing and Research College of Nursing.

StockTitan·
US
HCA
-0.29%
StockTitan·
US
HCA
-0.29%

Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium | GH Stock News

Guardant Health will present 14 abstracts at the 2025 San Antonio Breast Cancer Symposium, showcasing advancements in liquid biopsy tests for breast cancer. The presentations will highlight the efficacy of Guardant Reveal and Guardant360 Liquid in detecting cancer recurrence and monitoring treatment response. These studies demonstrate the potential of blood-based testing to guide treatment decisions and improve patient management across various stages of breast cancer.

StockTitan·
US
GH
-3.74%
StockTitan·
US
GH
-3.74%

Certain Common Stock of Guardant Health, Inc. are subject to a Lock-Up Agreement Ending on 5-DEC-2025.

Guardant Health, Inc.'s common stock is subject to a lock-up agreement ending on December 5, 2025. The lock-up period lasts 31 days, from November 4 to December 5, 2025. During this time, directors and executive officers cannot sell or transfer shares without consent from Goldman Sachs & Co. LLC and Jefferies LLC, with specified exceptions.

marketscreener·
US
GH
-3.74%
marketscreener·
US
GH
-3.74%
© 2025 Longbridge｜Disclaimer